Pre-IPO Briefing: Healthtech companies

Vincent's Slava Rubin and Sacra's Jan-Erik Asplund take an in-depth look at the Healthtech sector, and key startups Oura, Abridge, and Open Evidence, as well as OpenAI's impact on the industry.

Main points of the discussion include:

  • Health spending in the U.S. is a significant part of GDP.
  • Oura is a leading player in the smart health device market.
  • Abridge is revolutionizing doctor efficiency with AI scribes.
  • Open Evidence provides AI-driven support for medical professionals.
  • The health tech ecosystem is expanding with new opportunities.

Full Transcript

Level up your private markets game

Join Alternative Investing Report today.
✅ You're on the list!
Oops! Something went wrong while submitting the form.